COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,184 Articles (22,713 medRxiv, 8,471 bioRxiv)

Most recent first Previous |  Page 135: Articles 1341-1350  | Next

SARS-CoV-2 infection enhancement by Amphotericin B: Implications for disease management
Nguyen, D., Laidlaw, S. M., Dong, X., Wand, M. E., Horton, A., Sutton, M., Tree, J., Milligan, R., Erdmann, M., Matthews, D. A., Davidson, A. D., Rahman, K. M., Hiscox, J. A., Carroll, M. W.
10.1101/2024.11.07.622419 — Posted: 2024-11-07
A Single Chimeric Spike Antigen Induces Pan-Sarbecovirus Immunity
Counoupas, C., Pino, P., Armitano, J., Johansen, M., Smith, L., Chan, E., Ashley, C., Estape, E., Troyon, J., Alca, S., Miemczyk, S., Hansbro, N., Scandurra, G., Britton, W. J., Courant, T., Dubois, P., Collin, N., Mohan, V. K., Hansbro, P. M., Wurm, M., Wurm, F., Steain, M., Triccas, J.
10.1101/2024.11.06.622391 — Posted: 2024-11-07
Impact of different synonymous codon substitution strategies on SARS-CoV-2 nucleocapsid protein expression in Escherichia coli
Bello, A. J., Omotuyi, A. O., Oladapo, O. B., Adekunle, A. A., UDECHIME, K. U., Akinwande, A. B., Odewale, A. F., Adamson, O. O., Eban, D. O., Folarin, O., Okpuzor, J., Minari, J. B.
10.1101/2024.11.06.622014 — Posted: 2024-11-07
Persistent Health and Cognitive Impairments Up to Four Years Post-COVID-19 in Young Students: The Impact of Virus Variants and Vaccination Timing
Latifi, A., Flegr, J.
10.1101/2024.11.06.24316832 — Posted: 2024-11-06
Immunologic and Biophysical Features of the BNT162b2 JN.1- and KP.2-Adapted COVID-19 Vaccines
Chen, W., Tompkins, K. R., Windsor, I. W., Martinez, L. T., Ramos, M., Li, W., Shrivastava, S., Rajput, S., Chang, J. S., Sahasrabudhe, P., Fennell, K. F., McLellan, T. J., West, G. M., Dizon, K. P., Yam, A., Mitra, S., Saha, S., Sharaf, D., McKeen, A. P., Cadima, C. I., Muik, A., Swanson, W., Moreno, R. M., Daroca, P. M., Sahin, U., Anderson, A. S., Wu, H., Swanson, K. A., Modjarrad, K.
10.1101/2024.11.04.621927 — Posted: 2024-11-06
Nanoparticle-Supported, Rapid, Digital Quantification of Neutralizing Antibodies Against SARS-CoV-2 Variants
Mirjalili, S., Ikbal, M. A., Hou, C.-W., Kalatehmohammdi, M., Choi, Y., KELBAUSKAS, L., VanBlargan, L. A., Hogude, B. G., Murugan, V., Diamond, M. S., Wang, C.
10.1101/2024.11.05.622148 — Posted: 2024-11-06
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in experimental COVID-19
Rodrigues, P. B., de Rezende Rodovalho, V., Sencio, V., Benech, N., Creskey, M., Silva Angulo, F., Delval, L., Robil, C., Gosset, P., Machelart, A., Haas, J. T., Descat, A., Goossens, J. F., BEURY, D., Maurier, F., Hot, D., Wolowczuk, I., Sokol, H., Zhang, X., Ramirez Vinolo, M. A., Trottein, F.
10.1101/2024.11.05.622058 — Posted: 2024-11-06
Fatigue >12 weeks after coronavirus disease (COVID) is associated with reduced reward sensitivity during effort-based decision making
Scholing, J. M., Lambregts, B. I. H. M., van den Bosch, R., Aarts, E., van der Schaaf, M. E.
10.1101/2024.11.04.621806 — Posted: 2024-11-06
VirNA: a novel Minimum Spanning Networks algorithm for investigating viral evolution
Mazzotti, G., Bianco, L., Lavezzo, E., Bado, M., Fontana, P., Toppo, S.
10.1101/2024.11.05.620028 — Posted: 2024-11-06
Completion of multi-dose COVID-19 vaccines and the associated factors among adolescents and adults in two urban informal settlements in Nairobi, Kenya
Ng'oda, M., Izudi, J., Mwanga, D., Otieno, C., Sanya, R. E., Ziraba, A.
10.1101/2024.11.04.24316733 — Posted: 2024-11-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).